Rai, Dheeraj http://orcid.org/0000-0002-7239-3523
Webb, Doug
Lewis, Amanda
Cotton, Leonora
Norris, Jade Eloise
Alexander, Regi
Baldwin, David S.
Brugha, Traolach
Cochrane, Madeleine
Del Piccolo, Maria Chiara
Glasson, Emma J.
Hatch, Katherine K.
Kessler, David
Langdon, Peter E.
Leonard, Helen
MacNeill, Stephanie J.
Mills, Nicola
Morales, Maximiliano Vazquez
Morgan, Zoe
Mukherjee, Raja
Realpe, Alba X.
Russell, Ailsa
Starkstein, Sergio
Taylor, Jodi
Turner, Nicholas
Thorn, Joanna
Welch, Jack
,
Douglas, Sarah
Hale, Peter
O’Brien, Sarah
Walker, Amy
Wiles, Nicola
Funding for this research was provided by:
Health Technology Assessment Programme (NIHR127337)
National Health and Medical Research Council (GNT1171206)
Article History
Received: 26 September 2023
Accepted: 30 November 2023
First Online: 11 January 2024
Declarations
:
: Oxford B REC (22/SC/0296) [UK], South Metropolitan Health Service Human Research Ethics Committee, Government of Western Australia RGS0000003578 [Australia].Written informed consent will be obtained from all participants. To enable remote delivery of the trial, this will be captured via a MHRA (UK) and NHMRC & TGA (Australia) compliant eConsent process. An approved paper (wet ink) equivalent will be available where eConsent is not feasible.
: A copy of the consent form for the main trial is attached as a Supplementary file .
: DSB has received research funding from several pharmaceutical and biotechnology companies (including Pfizer Ltd., the developers of sertraline). He has attended advisory boards hosted by Idorsia (daridorexant), Liva Nova (transcranial direct current stimulation), and Mundipharma (methoxyflurane), any honoraria being paid to University of Southampton. He has received editorial honoraria from Wiley publishers, for editorship of <i>Human Psychopharmacology</i>.TSB has provided a one off consultancy for Roche, the honorarium being paid to the University of Leicester. HL was previously paid for one hour of consultancy by BioMedical Insights (San Francisco) in relation to CDKL5 deficiency disorder. She has also consulted for Marinus, Acadia, Avenix, Orion, Avanex and Newron on topics unrelated to this project, and all remuneration has been paid to her department.RM has received honoraria for talks on management of ADHD from Takeda and MEdice Pharmaceuticals, the funds directed to his team.All other authors declare that they have no competing interests.